Home › Funds › CDC Financial, Inc. › HCAT
CDC Financial, Inc. position in HCAT
HEALTH CATALYST INC · Information Technology
CDC Financial, Inc. reported holding 6,859,698 shares of HCAT (HEALTH CATALYST INC) in its Q3 2026 13F filing — a position valued at US$11.9M, representing 6.47% of its reported portfolio and ranking #3 among its reported holdings. CDC Financial, Inc. has disclosed HCAT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How CDC Financial, Inc.'s HCAT position evolved
CDC Financial, Inc. first disclosed a stake in HCAT in Q4 2025 at 4,002,046 shares (US$9.6M). The position peaked in Q2 2026 at 7,092,698 shares, worth US$14.1M. Across 4 filings, CDC Financial, Inc. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,859,698 shares valued at US$11.9M — a reduction of -233,000 shares quarter over quarter.. Notable position changes include a 58% increase in Q1 2026 (shares rose 57% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 4.00M | $9.56M | New |
| Q1 2026 | 6.31M | $8.01M | Add |
| Q2 2026 | 7.09M | $14.11M | Add |
| Q3 2026 | 6.86M | $11.87M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HCAT and 13F data
HCAT (HEALTH CATALYST INC) is a Information Technology company. 7 other funds we track also report a position in HCAT — the largest reported positions include First Light Asset Management, LLC (US$25.5M), Palogic Value Management, L.P. (US$9.8M), Nepsis Inc. (US$5.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HCAT
- First Light Asset Management, LLC 12.81M sh · $25.49M · Q2 2026
- Palogic Value Management, L.P. 4.92M sh · $9.80M · Q2 2026
- Nepsis Inc. 2.99M sh · $5.17M · Q3 2026
More on CDC Financial, Inc.
FAQ
How long has CDC Financial, Inc. held HCAT?
CDC Financial, Inc. has disclosed HCAT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is CDC Financial, Inc.'s current position in HCAT?
As of Q3 2026, CDC Financial, Inc. holds 6.86M shares of HCAT (HEALTH CATALYST INC), valued at $11.87M, representing 6.47% of its reported portfolio and ranking #3.
Has CDC Financial, Inc. been buying or selling HCAT?
In the latest 13F filing (Q3 2026), CDC Financial, Inc. reduced its position in HCAT. The position peaked in Q2 2026 at 7.09M shares.
Which other funds hold HCAT?
Other major institutional holders of HCAT include First Light Asset Management, LLC, Palogic Value Management, L.P., Nepsis Inc., among 7 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.